Cite
HARVARD Citation
Vashistha, V. et al. (2021). Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program. JCO oncology practice. 17 (7), p. . [Online].